Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Clinical Trial Comparing the Safety and Effectiveness of Axon Therapy for Post-Traumatic Peripheral Neuropathic Pain (PTPNP) to Conventional Medical Management (CMM)

NCT04795635 is registered in ClinicalTrials.gov with NeuraLace Medical, Inc. as lead sponsor.

NCT NCT04795635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04795635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Clinical Trial Comparing the Safety and Effectiveness of Axon Therapy for Post-Traumatic Peripheral Neuropathic Pain (PTPNP) to Conventional Medical Management (CMM)
Lead sponsor
NeuraLace Medical, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
April 14, 2021
Completion date
August 22, 2024
Enrollment
61 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathic pain, peripheral neuropathy